A carregar...
Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system
AIMS: To investigate the cost-effectiveness of once-daily insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in patients with type 2 diabetes not meeting glycemic targets on basal insulin from a healthcare payer perspective in Slovakia. METHODS: Long-term clinical and economic outcom...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731336/ https://ncbi.nlm.nih.gov/pubmed/29276398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S143127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|